Magnesium Citrate Oral Solution Cherry Flavor, 1.745 g per fl oz, packaged in 10 fl. oz ( 296 mL)...
FDA Drug Recall #D-0006-2018 — Class III — September 13, 2017
Recall Summary
| Recall Number | D-0006-2018 |
| Classification | Class III — Low risk |
| Date Initiated | September 13, 2017 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Vi-Jon, Inc. |
| Location | Smyrna, TN |
| Product Type | Drugs |
| Quantity | 87,972 bottles |
Product Description
Magnesium Citrate Oral Solution Cherry Flavor, 1.745 g per fl oz, packaged in 10 fl. oz ( 296 mL) bottles, Labeled as a) CVS Health, Distributed by: CVS Pharmacy, Inc. One CVS Drive, Woonsocket, RI 02895; NDC 6984238038, UPC 050428418321, b) Meijer, Dist. By Meijer Distribution, Inc. Grand Rapids, MI 49544, NDC 4125038038, UPC 708820824294, c) Life Brand, Manufactured for: Shoppers Drug Mark/Pharmaprix Toronto, UPC 057800856405
Reason for Recall
Failed Impurities/Degradation Specifications.
Distribution Pattern
United States and Canada
Lot / Code Information
Lot #: 0323439 Exp. 07/2018
Other Recalls from Vi-Jon, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0644-2022 | Class II | HEB 50% Isopropyl Alcohol First Aid Antiseptic,... | Mar 2, 2022 |
| D-0799-2021 | Class II | Kroger 70% Isopropyl Alcohol First Aid Antisept... | Sep 9, 2021 |
| D-0520-2019 | Class II | Topical Solution USP Hydrogen Peroxide First Ai... | Feb 20, 2019 |
| D-0073-2018 | Class III | Equate Beauty Clarifying Face Daily Moisturizer... | Sep 13, 2017 |
| D-0005-2018 | Class III | Magnesium Citrate Oral Solution Lemon Flavor, 1... | Sep 13, 2017 |
Frequently Asked Questions
Nitrosamines are probable human carcinogens — they can increase cancer risk with long-term exposure above certain thresholds, but they do not cause immediate harm from taking a single dose. The FDA calculates an acceptable daily intake (ADI) for each nitrosamine compound, and recalls are triggered when levels exceed this threshold. If you have been taking a recalled product, the FDA generally advises against abruptly stopping your medication (especially for critical conditions like blood pressure or diabetes) until you consult your doctor. The incremental cancer risk from short-term exposure is very small.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.